![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1808833
¼¼°èÀÇ ÀÓ»ó ÈÇÐ ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)Clinical Chemistry Market, By Product Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
ÀÓ»ó ÈÇÐ ½ÃÀåÀÇ ±Ô¸ð´Â 2024³â¿¡ 145¾ï 6,712¸¸ ´Þ·¯¿´À¸¸ç 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.6%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.
ÀÓ»ó ÈÇÐ ½ÃÀåÀº Ç÷¾×°ú ¼Òº¯°ú °°Àº ü¾×ÀÇ ÈÇÐ ¼ººÐ°ú »ýÈÇÐ ¼ººÐÀ» ÃøÁ¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â ºÐ¼®±â ¹× ½Ã¾àÀÇ °³¹ß, Á¦Á¶ ¹× ÀÀ¿ë¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â ´ç´¢º´, ½ÅÀå Àå¾Ö, °£ ±â´É ÀÌ»ó, ½ÉÇ÷°ü Áúȯ µî ´Ù¾çÇÑ Áúº´ÀÇ Áø´Ü, ¸ð´ÏÅ͸µ, °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÓ»ó ÈÇÐ ºÐ¼®±â´Â °Ë»ç ÇÁ·Î¼¼½º¸¦ ÀÚµ¿ÈÇÏ°í °¡¼ÓÈÇÏ¿© ÀÇ·á Á¾»çÀÚ¿¡°Ô Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ºÐ±¤ ±¤µµ°è, ÀÚµ¿ ºÐ¼®ÀåÄ¡, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»çÀåÄ¡ µîÀÇ Àåºñ°¡ Æ÷ÇԵ˴ϴÙ.
ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½ÇÇè½Ç ÀÚµ¿ÈÀÇ ÁøÀüÀ¸·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ °Ç°°ú À£´Ï½º¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í ½ÅÈï±¹ÀÇ °Ç° °ü¸® ÀÎÇÁ¶ó È®ÃæÀÌ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ºÐ¼®ÀåÄ¡ÀÇ ¼ÒÇüÈ¿Í µðÁöÅÐ °Ç° ±â¼ú°úÀÇ ÅëÇÕ°ú °°Àº ±â¼ú Çõ½Åµµ ½ÃÀåÀÇ Àü¸ÁÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÀÓ»ó ÈÇÐÀº ÃֽŠÁø´Ü°ú ¸ÂÃãÇü ÀÇ·áÀÇ ¿äÁ¡ÀÌ µÇ¾ú½À´Ï´Ù.
ÀÓ»ó ÈÇÐ ½ÃÀå - ½ÃÀå ¿ªÇÐ
½Å¼ÓÇϰí Á¤È®ÇÑ Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎ
½Å¼ÓÇϰí Á¤È®ÇÑ Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÓ»ó ÈÇÐ ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø ¿äÀÎÀÔ´Ï´Ù. Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç´Â ÀÇ·á Àü¹®°¡°¡ ȯÀÚ°¡ ÀÖ´Â °÷À̳ª °¡±îÀÌ¿¡¼ Áï½Ã Áø´Ü °á°ú¸¦ ¾òÀ» ¼ö ÀÖ°Ô ÇÏ¿© ½Å¼ÓÇÑ ÀÓ»ó ÆÇ´Ü°ú ½Ã±â ÀûÀýÇÑ Ä¡·á¸¦ ÃËÁøÇÕ´Ï´Ù. ÀÌ ÆíÀǼºÀº ÁýÁßÀûÀÎ ½ÇÇè½Ç °Ë»çÀÇ Çʿ伺À» ÁÙÀ̰í, ¼Ò¿ä ½Ã°£À» ´ÜÃàÇϸç, ȯÀÚ °á°ú¸¦ °³¼±ÇÕ´Ï´Ù.
ÀåºñÀÇ Áøº¸·Î ÀÌ·¯ÇÑ Àåºñ´Â º¸´Ù ÄÄÆÑÆ®ÇÏ°í »ç¿ëÇϱ⠽±°í ½Å·ÚÇÒ ¼ö ÀÖ°Ô µÇ¾î º´¿ø ¹× Ŭ¸®´Ð, ½ÉÁö¾î ¿ø°ÝÁö¿Í ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼ÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·á¿Í ÀçÅà ġ·á°¡ Áß½ÃµÇ¸é¼ Æ÷ÀÎÆ® ¿Àºê Äɾî(POC) ¼Ö·ç¼Ç ¼ö¿ä°¡ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼¼°è °Ç° °ü¸® ½Ã½ºÅÛÀÌ È¿À²¼ºÀ» ³ôÀÌ°í ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ ³ë·ÂÇÏ¸é¼ ÀÓ»ó ÈÇÐÀÇ Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç´Â ¿öÅ©Ç÷οìÀÇ °£¼ÒÈ¿Í ½Å¼ÓÇÑ Áø´Ü Áö¿øÀ» ÅëÇØ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ°í ±Ã±ØÀûÀ¸·Î ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
ÀÓ»ó ÈÇÐ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®
´ç»çÀÇ ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â)¿¡ ¾à 5.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¿¬°£ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
Á¦Ç° À¯Çüº°·Î ºÐ¼®±â´Â 2024³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.
±â¼ú ºÎ¹®º°·Î´Â 2024³â¿¡ Ãø±¤ ±â¼úÀÌ ÁÖ¿ä ±â¼ú·Î ³ªÅ¸³µ½À´Ï´Ù.
¿ëµµº°·Î ´ç´¢º´ °Ë»ç´Â 2024³â ÁÖ¿ä ¿ëµµ·Î ³ªÅ¸³µ½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â¿¡ ¼öÀÍÀ» âÃâÇÏ´Â ÁÖ¿ä ½ÃÀåÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
¼¼°èÀÇ ÀÓ»ó ÈÇÐ ½ÃÀåÀº Á¦Ç° À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐȵ˴ϴÙ.
½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ºÐ¼®±â, ½Ã¾à, ¼ÒÇÁÆ®¿þ¾î ¹× ¼ºñ½ºÀÇ ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÀÓ»ó ÈÇÐ ½ÃÀå¿¡¼´Â Á¦Ç° À¯Çüº°·Î´Â ºÐ¼®±â°¡ °¡Àå ¿ì¼¼ÇÕ´Ï´Ù. ºÐ¼®±â´Â Ç÷¾×°ú ¼Òº¯°ú °°Àº ȯÀÚ »ùÇÿ¡ ´ëÇØ ±¤¹üÀ§ÇÑ »ýÈÇÐÀû °Ë»ç¸¦ ¼öÇàÇÏ´Â µ¥ ÇʼöÀûÀÎ ÀåºñÀÔ´Ï´Ù. °Ë»ç ÇÁ·Î¼¼½º¸¦ ÀÚµ¿ÈÇÏ°í °£¼ÒÈÇÏ¿© ºü¸£°í Á¤È®ÇÏ¸ç ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ Á¦°øÇÕ´Ï´Ù. ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä´Â ¸¸¼º ÁúȯÀÇ È®»ê, ½ÇÇè½Ç ÀÚµ¿ÈÀÇ ÁøÀü, º´¿ø ¹× Áø´Ü¼¾ÅÍ¿¡¼ÀÇ °í󸮷® °Ë»çÀÇ Çʿ伺¿¡ ÀÇÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
°í±Þ ºÐ¼®±â´Â ÇöÀç ´ÙÁß ÆÄ¶ó¹ÌÅÍ °Ë»ç ±â´ÉÀ» Á¦°øÇÏ¿© »ùÇà ¾ç°ú ºÐ¼® ½Ã°£À» ´ÜÃàÇÏ¿© ÀÓ»ó È¿À²À» ³ôÀÔ´Ï´Ù. °Ô´Ù°¡ ÄÄÆÑÆ®ÇÏ°í »ç¿ëÇϱ⠽¬¿î Æ÷ÀÎÆ® ¿Àºê ÄɾîÇü ºÐ¼®ÀåÄ¡¿Í °°Àº ±â¼ú Çõ½Å¿¡ ÀÇÇØ ±× º¸±ÞÀº ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. Healthcare Provider´Â °³ÀÎÈ ¹× ¿¹¹æÀÇ·á Àü·«À» Áö¿øÇϱâ À§ÇØ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ºÐ¼®±âÀÇ ³ôÀº ºñ¿ëÀº Áø´Ü Á¤È®µµ¿Í ¿öÅ©Ç÷οì È¿À²¼º Çâ»óÀÇ Áß¿äÇÑ ¿ªÇÒ¿¡ ÀÇÇØ »ó¼âµÇ¸ç, ÀÌ ºÐ¾ß´Â ÀÓ»ó ÈÇÐ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.
½ÃÀåÀº ±â¼úº°·Î Ãø±¤, Àü±âÈÇÐ, Å©·Î¸¶Åä±×·¡ÇÇ, ¸é¿ªºÐ¼®, ±âŸÀÇ 5°¡Áö Ä«Å×°í¸®·Î ºÐ·ùµË´Ï´Ù. ÀÓ»ó ÈÇÐ ½ÃÀå¿¡¼´Â ±¤µµ°è ºÐ¾ß°¡ °¡Àå ¿ì¼¼ÇÕ´Ï´Ù. ±¤µµ°è´Â ÈÇÐ ¹ÝÀÀ Áß¿¡ Èí¼öµÇ°Å³ª ¹æÃâµÇ´Â ºûÀÇ °µµ¸¦ °¨ÁöÇÏ¿© »ýü ½Ã·áÀÇ ¹°Áú ³óµµ¸¦ ÃøÁ¤ÇÕ´Ï´Ù. ÀÌ ±â¼úÀº Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç ¿©·¯ °Ë»ç¸¦ µ¿½Ã¿¡ ó¸®ÇÒ ¼ö Àֱ⠶§¹®¿¡ ³Î¸® ¼±È£µË´Ï´Ù. ±¤µµ¹ýÀº ÀϹÝÀûÀ¸·Î Æ÷µµ´ç, ÄÝ·¹½ºÅ×·Ñ, È¿¼ÒȰ¼º°Ë»ç µîÀÇ ÀÏ»ó »ýÈÇÐ ÃøÁ¤¿¡ »ç¿ëµÇ¸ç, À̵éÀº ´Ù¾çÇÑ °Ç° »óÅÂÀÇ Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÔ´Ï´Ù.
Ãø±¤ºÐ¼®ÀåÄ¡´Â ¹ü¿ë¼ºÀÌ ³ô°í ºñ¿ë È¿°ú°¡ ¿ì¼öÇϱ⠶§¹®¿¡ º´¿ø, Áø´Ü¿¬±¸¼Ò, ¿¬±¸ ±â°ü µî¿¡¼ Æø³Ð°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ãø±¤ ±â¼úÀÇ ¹ßÀüÀ¸·Î °¨µµ°¡ Çâ»óµÇ°í ºÐ¼® ½Ã°£ÀÌ ´ÜÃàµÇ¾î ³ôÀº 󸮷®ÀÌ ÇÊ¿äÇÑ ÀÓ»ó ÇöÀå¿¡ ÀûÇÕÇÕ´Ï´Ù. ÀÚµ¿ÈµÈ ½Ã½ºÅÛ°úÀÇ È£È¯¼ºµµ °£¼ÒÈµÈ ¿öÅ©Ç÷ο츦 Áö¿øÇÏ¿© ÀÎÀû ¿À·ù¸¦ ÁÙÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕÇÏ¿© Ãø±¤±â¼úÀº ¼¼°èÀÇ ÀÓ»ó ÈÇÐ °Ë»ç¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
ÀÓ»ó ÈÇÐ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®
ºÏ¹Ì´Â ÷´Ü °Ç° °ü¸® ÀÎÇÁ¶ó¿Í Çõ½ÅÀûÀÎ Áø´Ü±â¼úÀÇ ³ôÀº µµÀÔ·ü¿¡ ÀÇÇØ ÀÓ»ó ÈÇÐ ½ÃÀå¿¡¼ Áß¿äÇÑ ÁöÀ§¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº Á¤ºÎÀÇ °·ÂÇÑ Áö¿ø°ú °Ç° °ü¸® ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ¸¹Àº ÅõÀÚ¸¦ ÅëÇØ ÀÓ»ó ÈÇÐ °Ë»çÀåºñ ¹× ½Ã¾àÀÇ Áö¼ÓÀûÀÎ °³¼±À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á½Ã¼³ÀÌ ÃæºÐÈ÷ Á¤ºñµÇ¾î °Ë»ç½Ç ¼ºñ½º°¡ ³Î¸® ÀÌ¿ë °¡´ÉÇÏ´Ù´Â Á¡ ¶ÇÇÑ º´¿ø, Áø´Ü¼¾ÅÍ, Áø·á¼Ò¿¡¼ÀÇ ÀÓ»ó ÈÇÐ °Ë»çÀÇ ±¤¹üÀ§ÇÑ À̿뿡 ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, Áúº´ÀÇ Á¶±â ¹ß°ß°ú °ü¸®¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡´Â ÀÌ·¯ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç¿Í ±â¼ú °ø±Þ±â¾÷°ú °Ç° °ü¸®±â°üÀÇ Çù·ÂÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ÀÓ»ó ÈÇаú µðÁöÅÐ °Ç° Ç÷§ÆûÀÇ ÅëÇÕÀ¸·Î ºÏ¹Ì´Â °ßÁ¶ÇÑ È®´ë°¡ ¿¹»óµÇ´Â ÁÖ¿ä ½ÃÀå Áö¿ªÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¹Ì±¹Àº °ß°íÇÑ °Ç° °ü¸® ÀÎÇÁ¶ó, ³ôÀº ÀÇ·áºñ, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ºñ¸¸ °ü·Ã Áúȯ µî ¸¸¼º ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ¼¼°èÀÇ ÀÓ»ó ÈÇÐ ½ÃÀåÀÇ ÃÖÀü¼±¿¡ ¼ ÀÖ½À´Ï´Ù. ÀÌ ³ª¶ó¿¡´Â º´¿ø, ¿Ü·¡Áø·á¼Ò, Áø´Ü°Ë»ç±â°ü µîÀÇ ±¤¹üÀ§ÇÑ ³×Æ®¿öÅ©°¡ ÀÖÀ¸¸ç ±âÃÊ´ë»ç, ÁöÁú, ½ÅÀå ±â´É °Ë»ç, °£ ±â´É °Ë»ç µîÀÇ Áß¿äÇÑ ÆÐ³ÎÀ» Æ÷ÇÔÇÑ ÀÓ»ó ÈÇÐ °Ë»ç¿¡ ´ëÇÑ Á¢±ÙÀÌ ³Î¸® È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿ÏÀü ÀÚµ¿ ÅëÇÕ ÀÓ»ó ÈÇÐ ºÐ¼®ÀåÄ¡°¡ °³¹ßµÇ¾î Áø´Ü Á¤È®µµ¿Í È¿À²¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ƯÈ÷ POCT(point-of-care testing: Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç) ÀåÄ¡°¡ º¸±ÞµÇ°í ÀÖÀ¸¸ç, ½Å¼ÓÇÏ°Ô ÇöÀå¿¡¼ °Ë»ç °á°ú¸¦ Á¦°øÇÔÀ¸·Î½á ±ä±Þ ½Ã ¶Ç´Â ¿ø°ÝÁö¿¡¼ÀÇ °Ë»ç¿¡ ƯÈ÷ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ÀÓ»ó ÈÇÐ ½ÃÀåÀÇ °æÀï ±¸µµ´Â Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Beckman Coulter, Bio-Rad Laboratories µî ¼¼°èÀû, Áö¿ªÀûÀ¸·Î À¯¸íÇÑ ±â¾÷ÀÌ ´Ù¼ö Á¸ÀçÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº Çõ½Å, Á¦Ç° ǰÁú, Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷Àº ³ôÀº Á¤¹Ðµµ¿Í ó¸® ½Ã°£ ´ÜÃàÀ» ½ÇÇöÇÏ´Â °í±Þ ÀÚµ¿ ºÐ¼®±â ¹× ½Ã¾àÀ» µµÀÔÇϱâ À§ÇÑ ¿¬±¸ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÇÕº´°ú Àμö´Â Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í Áö¸®Àû ¹üÀ§¸¦ È®´ëÇÏ´Â ÀϹÝÀûÀÎ Àü·«ÀÔ´Ï´Ù.
¶ÇÇÑ Ortho Clinical Diagnostics, Thermo Fisher Scientific, DiaSorin°ú °°Àº ±â¾÷Àº ÇöÁö ÆÇ¸ÅÀÚ ¹× ÀÇ·á Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞ¸¦ ÅëÇØ ½ÅÈï ½ÃÀå¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. °æÀï·ÂÀÖ´Â °¡°Ý ¼³Á¤, °·ÂÇÑ ÆÇ¸Å ÈÄ Áö¿ø ¹× Á¾ÇÕÀûÀÎ ¼ºñ½º¸¦ Á¦°øÇÔÀ¸·Î½á °¢ ȸ»ç´Â Â÷º°È¸¦ µµ¸ðÇϰí ÀÖ½À´Ï´Ù. Nova Biomedical»ç³ª Mindray Medical International»ç µî¿¡ ÀÇÇÑ Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç ±â±âÀÇ °³¹ß·Î Á¾·¡ÀÇ °Ë»ç½Ç À̿ܿ¡¼ÀÇ ½Å¼Ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿äÀÇ °íÁ¶¿¡ ´ëÀÀÇÏ¸é¼ °æÀïÀÌ °Ýȵǰí ÀÖ½À´Ï´Ù.
Clinical Chemistry Market size was valued at US$ 14,567.12 Million in 2024, expanding at a CAGR of 5.6% from 2025 to 2032.
The Clinical Chemistry Market focuses on the development, manufacturing, and Application of analytical instruments and reagents used to measure chemical and biochemical components in bodily fluids like blood and urine. These tests are essential for diagnosing, monitoring, and managing various diseases such as diabetes, kidney disorders, liver function abnormalities, and cardiovascular conditions. Clinical chemistry analyzers automate and speed up testing processes, providing accurate and reliable results for healthcare providers. The market includes equipment like spectrophotometers, autoanalyzers, and point-of-care testing devices.
Growth in this market is driven by the rising prevalence of chronic diseases, increasing demand for early disease detection, and advancements in laboratory automation. Additionally, growing awareness of health and wellness, along with the expansion of healthcare infrastructure in emerging economies, supports market growth. Innovations such as miniaturized analyzers and integration with digital health technologies are also shaping this market's future. Overall, clinical chemistry is a cornerstone of modern diagnostics and personalized medicine.
Clinical Chemistry Market- Market Dynamics
Rising demand for rapid, accurate point-of-care testing drives market growth.
The rising demand for rapid and precise point-of-care testing is a significant driver for the clinical chemistry market. Point-of-care testing enables healthcare professionals to obtain immediate diagnostic results at or near the patient's location, facilitating quicker clinical decisions and timely treatment. This convenience reduces the need for centralized laboratory testing, cutting down turnaround times and improving patient outcomes.
Advances in devices have made these devices more compact, user-friendly, and reliable, encouraging their adoption in hospitals, clinics, and even remote or resource-limited settings. Additionally, the growing emphasis on personalized medicine and home healthcare further boosts demand for point-of-care solutions. As healthcare systems worldwide strive to enhance efficiency and reduce costs, point-of-care testing in clinical chemistry plays a crucial role by streamlining workflows and supporting rapid diagnosis, ultimately propelling market growth.
Clinical Chemistry Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.6% over the forecast period (2025-2032)
Based on product type segmentation, Analyzers were predicted to show maximum market share in the year 2024
Based on Technology segmentation, photometric was the leading Technology in 2024
Based on Application segmentation, Diabetes Testing was the leading Application in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Clinical Chemistry Market is segmented on the basis of Product Type, Technology, Application, End-user, and Region.
The market is divided into four categories based on product type: Analyzers, Reagents, Software & Services. In the clinical chemistry market, the analyzers segment is the most dominant by product type. These analyzers are essential instruments that perform a wide range of biochemical tests on patient samples such as blood and urine. They automate and streamline testing processes, delivering fast, accurate, and reliable results that are critical for diagnosing and managing diseases. The demand for analyzers is driven by the growing prevalence of chronic diseases, increasing laboratory automation, and the need for high-throughput testing in hospitals and diagnostic centers.
Advanced analyzers now offer multi-parameter testing capabilities, reducing sample volumes and turnaround times, which enhances clinical efficiency. Additionally, innovations such as compact, user-friendly, and point-of-care analyzers have further expanded their adoption. Healthcare providers increasingly rely on these devices to support personalized medicine and preventive care strategies. The high cost of analyzers is offset by their critical role in improving diagnostic accuracy and workflow efficiency, making this segment a key growth driver in the clinical chemistry market.
The market is divided into five categories based on Technology: Photometric, Electrochemical, Chromatography, Immunoassay, and Others. In the clinical chemistry market, the photometric segment is the most dominant. Photometric analyzers measure the concentration of substances in biological samples by detecting the intensity of light absorbed or emitted during chemical reactions. This technology is widely preferred due to its high accuracy, reliability, and ability to process multiple tests simultaneously. Photometric methods are commonly used for routine biochemical assays such as glucose, cholesterol, and enzyme activity testing, which are critical for diagnosing and monitoring various health conditions.
The versatility and cost-effectiveness of photometric analyzers contribute to their extensive use in hospitals, diagnostic laboratories, and research institutions. Furthermore, advancements in photometric technologies have improved sensitivity and reduced analysis time, making them suitable for high-throughput clinical settings. Their compatibility with automated systems also supports streamlined workflows and reduces human error. These factors collectively reinforce the photometric Technology as the backbone of clinical chemistry testing worldwide.
Clinical Chemistry Market- Geographical Insights
North America holds a prominent position in the clinical chemistry market, driven by its advanced healthcare infrastructure and high adoption of innovative diagnostic technologies. The region benefits from strong government support and substantial investments in healthcare research and development, fostering continuous improvements in clinical chemistry instruments and reagents. Well-established healthcare facilities and widespread availability of laboratory services contribute to the extensive use of clinical chemistry testing across hospitals, diagnostic centers, and clinics.
Additionally, growing awareness about early disease detection and management fuels demand for these diagnostic tools. The presence of key players and collaboration between Technology providers and healthcare institutions further enhance market growth. Moreover, increasing focus on personalized medicine and the integration of clinical chemistry with digital health platforms positions North America as a leading market region with steady expansion prospects.
The United States stands at the forefront of the global clinical chemistry market, driven by its robust healthcare infrastructure, substantial healthcare spending, and a high prevalence of chronic diseases such as diabetes, cardiovascular disorders, and obesity-related conditions. The nation's extensive network of hospitals, outpatient clinics, and diagnostic laboratories facilitates widespread access to clinical chemistry testing, encompassing essential panels like basic metabolic, lipid, renal, and liver function tests. Technological advancements have led to the development of fully automated and integrated clinical chemistry analyzers, enhancing diagnostic accuracy and efficiency. Notably, point-of-care testing (POCT) devices are gaining traction, offering rapid, on-site results that are particularly beneficial in emergency and remote settings.
The competitive landscape of the clinical chemistry market is marked by the presence of several well-established global and regional players such as Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Beckman Coulter, and Bio-Rad Laboratories. These companies compete through innovation, product quality, and strategic partnerships. Key players focus heavily on research and development to introduce advanced, automated analyzers and reagents that offer greater accuracy and faster processing times. Mergers and acquisitions are common strategies to expand product portfolios and geographical reach.
Additionally, companies like Ortho Clinical Diagnostics, Thermo Fisher Scientific, and DiaSorin are investing in emerging markets through collaborations with local distributors and healthcare providers. Competitive pricing, strong after-sales support, and comprehensive service offerings differentiate players. The development of point-of-care testing devices by firms such as Nova Biomedical and Mindray Medical International also intensifies competition, as they cater to the growing demand for rapid diagnostics outside traditional laboratory settings.
In January 2024, Beckman Coulter introduced the DxC 500 AU Chemistry Analyzer, an automated system designed for small to medium-sized laboratories. This launch aims to enhance laboratory operations and support clinical decision-making.